Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.311 | A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participants with Elevated Lipoprotein(a) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2024.478 | Gaps in Awareness of Cardiovascular Diseases: A Cross Sectional Study | Prof. YAN Bryan Ping Yen |
| 2025.242 | A single arm, multicenter, open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) in participants who completed the parent Lp(a)HORIZON trial | Prof. YAN Bryan Ping Yen |
| 2024.468 | AI-Based Intima-Media Thickness Measurement for Cardiovascular Risk Assessment |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2011.234 | Predicting Outcomes in Acute Coronary Syndrome: A Translational Approach Integrating Population-Specfic Clinical Risk Models, Platelet Reactivity and Metabolomic Biomarkers | Prof. YAN Bryan Ping Yen |
| 2013.607 | Dyslipidemia International Study II (DYSIS II) | Dr Yan Bryan Ping Yen |
| 2011.237 | Management and Prognosis of Patients with Minor Coronary Artery Disease | Prof. Yan Bryan Ping Yen |
| 2009.581 | In Vivo Assessment of Plaque Morphology and Vessel Injury during Percutaneous Coronary Intervention sing Intravasclar High-Resolution Optical Coherence Tmographic Imaging | Prof. Yan Bryan Ping Yen |
| 2011.166 | Assessment of circulating microRNAs in patients with coronary artery disease as novel biomarkers for peri-procedural myocardial necrosis and in-stent restenosis after percutaneous coronary intervention | Prof. Yan Bryan Ping Yen |
| 2009.542 | Impact of unrecognized peripheral arterial disease and additional prognostic value of ankle-brachial index to risk-stratify patients at high cardiovascular risk undergoing coronary angiography or intervention | Prof. YAN Bryan Ping Yen |
| 2013.082 | Physiologic-Guided Endovascular Revascularization for the Treatment of Atherosclerotic Erectile Dysfunction in Chinese Patients with Suboptimal Response to Pharmacotherapy: A Pilot Study | Prof. YAN Bryan Ping Yen |
| 2010.123 | Cardiovascular Risk Profile & Long-term Clinical Outcomes of Patients with Peripheral Arterial Disease in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2009.543 | Patients at High Cardiovascular Risk Lack Awareness of the Importance of Risk Factor Modification and the Dire Consequences Associated with Peripheral Artery Disease : A cross sectional cohort study | Prof. YAN Bryan Ping Yen |
| 2015.296 | International Survey on Current Status & Future of Drug-Eluting Stents |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.319 | Investigation on the novel noninvasive sensors and algorithms for validating cuffless continuous blood pressure measurement. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.297 | Optical Coherence Tomography evaluation of Very Early eNdothelialization after Dual Therapy Drug-eluting Stent with EPC CaptURE (OCT-VENTURE) |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.381 | Multinational Abluminal Sirolimus Coated BiO-Engineered StenT – The MASCOT Post Marketing Registry | Dr. YAN Bryan Ping Yen |
| 2016.630 | Renal Artery Sympathetic Denervation by Catheter Ablation after Pulmonary Vein Isolation (PVI) for Persistent Atrial Fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.638 | Defining the athletes heart phenotype: A comparison of male Caucasian and East Asian elite footballers and rugby players |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.291 | Optimal Bioabsorbable Vascular Scaffold Technique for Complex Bifurcation Lesions |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2015.542 | East Asian ALDH2 polymorphism and impact on myocardial infarct size |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.003 | Implantation of the Venus P-ValveTM in the Pulmonic Position in Patients with Native Outflow Tracts |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.292 | A novel non-invasive radial artery tonometric cardiovascular monitoring device for assessment of vascular aging, subclinical atherosclerosis and cardiovascular risk in the elderly. |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2015.302 | ASTRI Wireless ECG Module Public Trial |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.258 | A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting with Acute Coronary Syndrome Treated with Losmapimod Compared to Placebo | Prof. YAN Bryan Ping Yen |
| 2016.401 | BIOTRONIKS - Safety and Performance in de Novo Lesion of Native Coronary Arteries with Magmaris - Registry: BIOSOLVE-IV | Dr. YAN Bryan Ping Yen |
| 2016.623 | Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong | Dr. YAN Bryan Ping Yen |
| 2015.301 | Effects of Cardiovascular Autonomic Nervous System Activities on BP/ECG/PPG/Respiratory Related Physiological Features, Validation of Improved PTT-based Cuffless BP Estimation with IEEE 1708 Standard, and Measurement of Respiratory Rate with a Novel Method |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.370 | Patient education, monitoring and support to enhance adherence to dabigatran in patients with non-valvular atrial fibrillation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.265 | The Effect of CYP2C19 Genetic Variants on Clinical Outcomes in Post-Angioplasty Patients Treated with Clopidogrel |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2014.603 | HK-GP AF Screening & Education Program | Prof. YAN Bryan Ping Yen |
| 2014.380 | A pilot study to assess efficacy and safety of a novel Titanium-Nitride coated woven-nitinol Peripheral Arterial Stent | Prof. YAN Bryan Ping Yen |
| 2016.509 | Hong Kong Percutaneous Coronary Intervention Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.358 | Optical Coherence Tomography evaluation of Bioabsorbable Vascular Scaffold Technique with Magmaris | Prof. YAN Bryan Ping Yen |
| 2017.316 | Electrical Activation Mapping Guided Tailor Made Approach for Cardiac Resynchronization Therapy | Prof. YAN Bryan Ping Yen |
| 2016.550 | Validation of Camera-based Measurement of Finger & Facial Photoplethysmographic Signal for Heart Rate and Arrhythmias Detection |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.234 | PWH Cardiac Implantable Electronic Devices (CIED) Home Monitoring Registry |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.490 | Development of personalized medicine using Prenetics iGenes pharmacogenomic panel to predict individual responses to cardiovascular drugs |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2016.531 | Prospective Observational study of Lipid Management in Non-US, Non-Western European Patients Who Have A Recent Acute Coronary Syndrome Event |
Dr. YAN Bryan Ping Yen 甄秉言 |
| 2014.653 | Changing Pattern of Revascularization for Critical Limb Ischemia towards an Endovascular First Approach in Hong Kong | Prof. YAN Bryan Ping Yen |
| 2017.266 | Novel Serum Biomarkers Associated with Atherosclerosis-related Vascular Diseases: A Translational Approach | Prof. YAN Bryan Ping Yen |
| 2016.456 | Diagnostic Accuracy and Incremental Prognostic Value of Exercise MCG in Patients at Risk of Coronary Artery Disease |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2017.366 | ACCelerated ThrombolySiS for Post-Thrombotic Syndrome Using the EKOS System |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2026.531 | Clinical trajectories, risk factors and outcomes in patients with peripheral artery disease |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2026.273 | A Multi-national, non-interventional stUdy of bempedoic acid or its Single-pill combinAtion therapy with ezetimibe in routine clinical practice in patientS with primary Hypercholesterolaemia or mIxed dyslipidaemia – Musashi Study | Prof. Yan Bryan Ping Yen |
| 2022.287 | Validation of a novel device for screening patients with atrial fibrillation / arrhythmia | Prof. YAN Bryan Ping Yen |
| 2021.717 | In-hospital initiation of empagliflozin for the treatment of new-onset acute heart failure regardless of ejection fraction: A Pilot Study |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2022.335 | Evaluation of the Relationship Between Arterial Stiffness and Coronary Artery Disease by Stroke-Volume-Allocation |
Prof. YAN Bryan Ping Yen 甄秉言 |
| 2021.400 | LIFE-BTK (pivotaL Investigation of saFety and Efficacy of BRS treatment-Below The Knee) Randomized Controlled Trial |
Prof. YAN Bryan Ping Yen 甄秉言教授 |
| 2021.718 | The effects and cost-effectiveness of a technology-based family-centered empowerment (T-FAME) program on health and health service utilization outcomes of post-discharged patients with advanced heart failure: A sequential mixed method study |
Prof. YAN Bryan Ping Yen 甄秉言 |
Page 270 of 289.

